Frazier Financial Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History
Frazier Financial Advisors, LLC
- $163 Billion
- Q3 2025
A detailed history of Frazier Financial Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 500 shares of AUPH stock, worth $7,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 1,000
50.0%
Holding current value
$7,675
Previous $8.47 Million
34.77%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding AUPH
# of Institutions
267Shares Held
69.3MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...